VENTURA, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.248
EU - Europa 18.168
AS - Asia 10.590
SA - Sud America 1.533
Continente sconosciuto - Info sul continente non disponibili 296
AF - Africa 215
OC - Oceania 42
Totale 54.092
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.733
IT - Italia 6.008
GB - Regno Unito 4.842
SG - Singapore 3.054
SE - Svezia 2.833
CN - Cina 2.828
BR - Brasile 1.154
HK - Hong Kong 1.151
DE - Germania 1.083
VN - Vietnam 1.070
BD - Bangladesh 664
FI - Finlandia 637
FR - Francia 635
UA - Ucraina 568
TR - Turchia 401
RU - Federazione Russa 397
KR - Corea 353
NL - Olanda 320
IN - India 286
CA - Canada 285
BG - Bulgaria 178
ID - Indonesia 150
AR - Argentina 135
MX - Messico 109
PL - Polonia 104
IQ - Iraq 91
JP - Giappone 83
BE - Belgio 81
ZA - Sudafrica 75
ES - Italia 72
IE - Irlanda 69
MY - Malesia 62
AE - Emirati Arabi Uniti 53
CO - Colombia 53
EC - Ecuador 48
RO - Romania 44
CH - Svizzera 43
CL - Cile 42
LT - Lituania 40
VE - Venezuela 38
AT - Austria 36
CZ - Repubblica Ceca 36
AU - Australia 35
PH - Filippine 34
PK - Pakistan 32
UZ - Uzbekistan 30
SA - Arabia Saudita 27
CR - Costa Rica 25
IR - Iran 23
JO - Giordania 23
PE - Perù 23
JM - Giamaica 22
MA - Marocco 22
PY - Paraguay 21
AZ - Azerbaigian 20
DZ - Algeria 19
EG - Egitto 19
GR - Grecia 19
IL - Israele 19
NP - Nepal 19
PT - Portogallo 19
NO - Norvegia 17
TH - Thailandia 17
TN - Tunisia 17
TW - Taiwan 15
KE - Kenya 14
AL - Albania 12
EU - Europa 12
TT - Trinidad e Tobago 12
BO - Bolivia 11
GT - Guatemala 11
KG - Kirghizistan 11
BH - Bahrain 10
HN - Honduras 10
RS - Serbia 9
SY - Repubblica araba siriana 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
PR - Porto Rico 8
BY - Bielorussia 7
CY - Cipro 7
ET - Etiopia 7
MD - Moldavia 7
NI - Nicaragua 7
OM - Oman 7
SK - Slovacchia (Repubblica Slovacca) 7
HU - Ungheria 6
MK - Macedonia 6
NG - Nigeria 6
NZ - Nuova Zelanda 6
UY - Uruguay 6
AM - Armenia 5
KZ - Kazakistan 5
LU - Lussemburgo 5
PA - Panama 5
PS - Palestinian Territory 5
SC - Seychelles 5
SN - Senegal 5
CI - Costa d'Avorio 4
HR - Croazia 4
Totale 53.728
Salva come PNG Salva come JPEG
Città #
Southend 3.859
Ashburn 2.345
Santa Clara 2.019
Singapore 1.898
Stockholm 1.800
Fairfield 1.791
Chandler 1.194
Hong Kong 1.128
Woodbridge 1.108
Houston 1.095
San Jose 1.059
Hefei 930
Jacksonville 823
Ann Arbor 621
Seattle 612
Wilmington 599
Council Bluffs 585
Dearborn 574
Cambridge 568
London 556
Nyköping 555
Beijing 554
Helsinki 469
Rome 426
Los Angeles 416
Milan 404
Ho Chi Minh City 368
Chicago 360
Dallas 343
Seoul 337
New York 284
The Dalles 258
Modena 251
Hanoi 238
Berlin 212
Izmir 196
San Diego 186
Princeton 181
Sofia 169
Eugene 150
Munich 147
Lauterbourg 142
Buffalo 127
São Paulo 119
Moscow 115
Shanghai 111
Salt Lake City 108
Bologna 105
Naples 103
Columbus 94
Orem 94
Sunnyvale 91
Bremen 89
Jakarta 89
Boardman 84
Toronto 84
Phoenix 82
Des Moines 78
Frankfurt am Main 75
Parma 75
Palermo 73
Brussels 68
Florence 66
Rimini 66
Warsaw 66
Montreal 65
Verona 62
Tokyo 61
Atlanta 57
Turin 57
Amsterdam 56
Denver 53
Redwood City 53
Catania 52
Chennai 52
Bari 51
Yalova 50
Dublin 49
Falls Church 49
Da Nang 47
Boston 46
Tampa 45
Rio de Janeiro 44
Brooklyn 42
Haiphong 42
Mexico City 42
Johannesburg 41
San Francisco 41
Elk Grove Village 37
Fremont 37
Guangzhou 36
Manchester 36
Turku 35
Mumbai 34
Paris 33
Miano 32
Padova 32
Poplar 31
Dhaka 30
Brasília 29
Totale 35.431
Salva come PNG Salva come JPEG
Nome #
Effetti dell’insulina sui livelli di omocisteina plasmatica in pazienti con diabete mellito tipo ii con e senza intolleranza alla metionina 2.547
Alterations in iron status predict cardiac response to blood transfusion in -thalassemia major 1.845
Validating the Body Uneasiness Test (BUT) in obese patients 729
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 723
Weight Loss Expectations in Obese Patients and Treatment Attrition: An Observational Multicenter Study 714
Trombosi portale e iperomocisteinemia in pazienti con cirrosi epatica 686
Oxford Manuale di Medicina Clinica 660
Isomeri urinari della Coproporfirina in pazienti con Epatopatie Colestatiche Acquisite e sindrome di Dubin-Johnson 608
Impiego dei marcatori di neoplasia (CEA, CA 19.9, CA 125, CA 16.3, NSE) in Medinina Interna: uno studio retrospettivo 581
The QUOVADIS Study: features of obese Italian patients seeking treatment at specialist centers 521
Urinary and plasma homocysteine and cysteine levels during prolonged oral N-acetylcysteine therapy 512
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 511
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 505
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 497
Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics 489
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 484
Red wine consumption prevents vascular oxidative stress induced by a high-fat meal in healthy volunteers 481
A challenging diagnosis for potential fatal diseases: Recommendations for diagnosing acute porphyrias 439
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 436
Acute Intermittent Porphyria in a Child with Severe Neuropathy 418
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 412
Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature 410
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 408
Safety and efficacy of sucrosomal iron in inflammatory bowel disease patients with iron deficiency anemia 404
The Acute Porphyric Attack: A Difficult Diagnosis for a Potential Lethal Event in Emergency Medicine 386
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks 382
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 373
A role for homocysteine increase in haemolysis of megaloblastic anaemias due to vitamin B-12 and folate deficiency: results from an in vitro experience 366
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 366
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 362
N-acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion 355
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 354
HYPERHOMOCYSTEINEMIA AND MTHFR C677T POLYMORPHISM IN PATIENTS WITH PORTAL VEIN THROMBOSIS COMPLICATING LIVER CIRRHOSIS 346
Antiviral treatment profoundly affects iron status in HCV patients: Implications for management and treatment outcome 342
IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS? 342
MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS. 340
Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects 340
Hepatocellular Carcinoma in HIV-infected Patients: Check Ealy, Treat Hard 337
Alendronate treatment for osteoporosis in patients infected with human immunodeficiency virus. 336
Weight Loss Expectations in Obese Patients Seeking Treatment at Medical Centers 334
A large deletion on chromosome 11 in acute intermittent porphyria 330
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 328
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 324
Drugs and acute porphyrias: reasons for a hazardous relationship 323
The Metabolic Syndrome in Treatment-Seeking Obese Persons 321
Psychological Distress in Morbid Obesity in Relation to Weight History 320
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 319
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. 314
MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma 314
HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCCAND LIVER CIRRHOSIS 312
Tumour markers in internal medicine: a low-cost test or an unnecessary expense? A retrospective study based on appropriateness 309
Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians 309
Anti- and pro-oxidant factors and endothelial dysfunction in chronic cigarette smokers with coronary heart disease 309
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 306
Guidelines for the management of acute porphyria: recommendations from the International Porphyria Network 305
EXPLORE: A prospective, multinational natural history study of acute hepatic porphyria patients with recurrent attacks 305
Molecular characterization, by digital PCR analysis of four HMBS gene mutations affecting the ubiquitous isoform of Porphobilinogen Deaminase (PBGD) in patients with Acute Intermittent Porphyria (AIP) 304
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 303
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 302
Clinical, biochemical and genetic characteristics of Variegate Porphyria in Italy 299
Radiofrequency ablation combined with transcatheter arterial chemioembolization in the treatment of advanced hepatocellular carcinoma 296
Pro-oxidant and antioxidant factors in acute intermittent porphyria: Family studies 295
Weight cycling in treatment-seeking obese persons: data from the QUOVADIS study 293
Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives 293
Urinary coproporhyrin isomers during therapy with IFn-RIBA in patients with chronic hepatitis due to HCV infection 287
Flow-mediated dilatation (FMD) assessment as a marker of endothelial dysfunction in liver cirrhosis 286
Continuous combined hormone replacement therapy with oral 17β-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women 285
Affinità dell'omocisteina per le lipoproteine 285
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy 284
Role of Multidrug-Resistance Protein 2 in coproporphyrin transport: results from experimental studies in bile fistula rat models 282
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 282
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 276
Prevention of a first episode of variceal bleeding: role of duplex Doppler sonographic measurement of the acute response to beta-blockers. 274
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 271
The Effect of Obesity Management on Body Image in Patients Seeking Treatment at Medical Centers 269
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 267
Portal vein thrombosis and thrombophilia in liver cirrhosis: a role for hyperhomocysteinemia ? 265
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 265
Relevance of different apolipoprotein content in binding of homocysteine to plasma lipoproteins 263
Snoring, hypertension and Type 2 diabetes in obesity. Protection by physical activity 263
Serum endothelin-1 as predictor of ascitic decompensation in patients with liver cirrhosis 262
Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats 262
THE INTERACTION OF BILIAR ACIDS WITH 2-HYDROXYPROPYL-CYCLODEXTRIN IN SOLUTION AND IN THE SOLID STATE 259
Correlation between plasma malonyldialdeide levels and paroxonase activity in healthy subjects and in patients with atherosclerotic disease 257
Rilevanza del diverso contenuto apolipoproteico nel legame dell’omocisteina alle lipoproteine 255
Recovery of chronic motor neuropathy due to acute intermittent porphyria after givosiran treatment in a young boy: a case report 254
Acute Hepatic Porphyrias: “Purple Flags”—Clinical Features that should Prompt Specific Diagnostic Testing 254
Does the measurement of portal flow velocity have any value in the identification of patients with cirrhosis at risk of digestive bleeding ? 252
Improvement of survival in patients with intermediate stage (BCLC-B) hepatocellular acrcinoma complicating liver cirrhosis by combination therapy with radiofrequency ablation and transcatheter chemioembolization 249
Ataxia-myoclonus syndrome in patients with SARS-CoV2 infection 249
Peroxidation indices and total antioxidant capacity in plasma during hyperhomocysteinemia induced by methionine oral loading 248
Alendronate for the treatment of Osteoporosis in HIV-infected patients. 248
Sarcoma primitivo del cuore. Descrizione di un caso 248
Iron Metabolism in the Disorders of Heme Biosynthesis 247
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria 247
Plasma nitric oxide production during acute hyperhomocysteinemia in atherosclerotic patients and controls 246
Distribution of homocysteine in plasma lipoproteins 245
Markers of Endothelial Dysfunction in patients with liver cirrhosis with anh without portal hypertension 245
Impact of nutrition on cognition and affectivity in the elderly: A review 242
Efficacy and safety of combination therapy with pegylated interferon and ribavirin in aged patients with chronic hepatitis C 239
Totale 38.526
Salva come PNG Salva come JPEG
Categoria #
all - tutte 177.544
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 177.544
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.079 0 0 290 308 143 217 211 219 407 316 538 430
2022/20234.119 423 420 318 370 452 551 118 389 491 112 229 246
2023/20242.739 168 179 241 227 399 196 225 336 115 124 192 337
2024/20258.142 322 149 325 583 1.543 1.083 598 494 885 337 858 965
2025/202617.715 1.010 748 1.368 1.491 1.785 1.117 1.782 828 3.445 1.625 1.487 1.029
2026/20272.526 1.008 1.438 80 0 0 0 0 0 0 0 0 0
Totale 54.092